Biotech Buys: 2 Top Picks Under $10
As a result of the pandemic, investors have likely become familiar with a number of biotech names over the past year and a half that…
As a result of the pandemic, investors have likely become familiar with a number of biotech names over the past year and a half that…
Assessing the current state of the biotech industry, the author of today’s article notes that “While the coronavirus treatments will take center stage in 2021,…
With the pandemic forcing patients/providers to alter the way they sought/delivered health care, the digital health industry gained momentum last year. In a recent report,…
“The dumb money was the smart money this year,” is how one portfolio manager cited in today’s article sums up the wild swings experienced by…
“Investors have rewarded tech stocks richly during, and prior to the pandemic. Yet, there are gems that remain hidden within the sector,” advises the author…
If you’re looking for an options trade with the potential to nearly double your money, today’s article outlines one such trade to consider. Specifically, as…